Immunovant (IMVT) Current Leases (2020 - 2026)
Immunovant (IMVT) posted Current Leases of $72000.0 for Q1 2026, down 26.53% on a QoQ basis from $98000.0 in Q1 2025, and down 26.53% year-over-year from $98000.0 in Q1 2025.
Immunovant (IMVT) Current Leases (2020 - 2026) Analysis & Trends
Immunovant's Current Leases history runs 7 years deep, the most recent figure standing at $72000.0 for Q1 2026.
- Quarterly Current Leases fell 26.53% year-over-year to $72000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72000.0 (down 26.53% YoY) and the FY2026 annual result came in at $72000.0, down 26.53% from the prior year.
- Current Leases was $72000.0 for Q1 2026 at Immunovant, down from $98000.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.2 million in Q4 2022 and bottomed at $23000.0 in Q4 2024.
- A 5-year average of $582785.7 and a median of $460000.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases rose 11.68% — and 2024, when it slumped 92.49%.
- Immunovant's Current Leases stood at $1.2 million in 2022, then tumbled by 74.61% to $306000.0 in 2023, then tumbled by 92.48% to $23000.0 in 2024, then surged by 326.09% to $98000.0 in 2025, then slipped by 26.53% to $72000.0 in 2026.
- Business Quant data shows IMVT's Current Leases at $72000.0 in Q1 2026, $98000.0 in Q1 2025, and $23000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Immunovant | 7.18 Bn | 7.18 Bn | - | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 306,000.00 |
| Sep 30, 2023 | 614,000.00 |
| Jun 30, 2023 | 919,000.00 |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | 1.10 Mn |
| Sep 30, 2020 | 1.10 Mn |